drugset / Trial / NCT02049814
Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the efficacy of voglibose versus acarbose combined with metformin in participants with type 2 diabetes mellitus (T2DM) by evaluating levels of glycosylated hemoglobin.
Timeline
- Start
- 2014-05-09
- Primary completion
- 2016-06-01
- Completion
- 2016-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acarbose | Unknown | 100 mg | Oral |
| Subject | Voglibose | Small molecule | 0.3 mg | Oral |
| Background | Metformin | Small molecule | 1000 mg | Oral |